RetractedArticleBMC cancer2013

A synthetic dsRNA, as a TLR3 pathwaysynergist, combined with sorafenib suppresses HCC in vitro and in vivo.

Yu-Yin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.